| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Antibody–drug conjugates targeting RON receptor tyrosine kinase as a novel strategy for treatment of triple-negative breast cancer
|
Yao, Hang-Ping
|
|
|
25 |
7 |
p. 1160-1173
|
artikel
|
| 2 |
Apoptosis as a mechanism for the treatment of adult T cell leukemia: promising drugs from benchside to bedside
|
Houssein, Marwa
|
|
|
25 |
7 |
p. 1189-1197
|
artikel
|
| 3 |
Assessment of significant benefit for orphan medicinal products by European regulators may support subsequent relative effectiveness assessments by health technology assessment organizations
|
Vreman, Rick A.
|
|
|
25 |
7 |
p. 1223-1231
|
artikel
|
| 4 |
A systems biology approach for studying neurodegenerative diseases
|
Lam, Simon
|
|
|
25 |
7 |
p. 1146-1159
|
artikel
|
| 5 |
Chiral switches of chloroquine and hydroxychloroquine: potential drugs to treat COVID-19
|
D’Acquarica, Ilaria
|
|
|
25 |
7 |
p. 1121-1123
|
artikel
|
| 6 |
Comprehensive approach of hybrid nanoplatforms in drug delivery and theranostics to combat cancer
|
Thorat, Nanasaheb D.
|
|
|
25 |
7 |
p. 1245-1252
|
artikel
|
| 7 |
Computer-aided designing of oncolytic viruses for overcoming translational challenges of cancer immunotherapy
|
Lathwal, Anjali
|
|
|
25 |
7 |
p. 1198-1205
|
artikel
|
| 8 |
Contents page 2
|
|
|
|
25 |
7 |
p. ii
|
artikel
|
| 9 |
Contents page 1
|
|
|
|
25 |
7 |
p. i
|
artikel
|
| 10 |
Current and future approaches to nonclinical cardiovascular safety assessment
|
Collins, Teresa A.
|
|
|
25 |
7 |
p. 1129-1134
|
artikel
|
| 11 |
ET-traps offer a potential therapeutic tool for use in different autoimmune diseases
|
Jain, Arjun
|
|
|
25 |
7 |
p. 1142-1145
|
artikel
|
| 12 |
Extracellular vesicles from mesenchymal stem cells as a Covid-19 treatment
|
O’Driscoll, Lorraine
|
|
|
25 |
7 |
p. 1124-1125
|
artikel
|
| 13 |
In silico design of telomerase inhibitors
|
Baginski, Maciej
|
|
|
25 |
7 |
p. 1213-1222
|
artikel
|
| 14 |
Long noncoding RNAs in nonalcoholic fatty liver disease and liver fibrosis: state-of-the-art and perspectives in diagnosis and treatment
|
De Vincentis, Antonio
|
|
|
25 |
7 |
p. 1277-1286
|
artikel
|
| 15 |
Multiple approaches for achieving drug solubility: an in silico perspective
|
Das, Torsa
|
|
|
25 |
7 |
p. 1206-1212
|
artikel
|
| 16 |
Neoadjuvant chemotherapy-related platinum resistance in ovarian cancer
|
Liu, Jiahao
|
|
|
25 |
7 |
p. 1232-1238
|
artikel
|
| 17 |
‘PARP’ing fibrosis: repurposing poly (ADP ribose) polymerase (PARP) inhibitors
|
Rao, Pooja Dhileepkumar
|
|
|
25 |
7 |
p. 1253-1261
|
artikel
|
| 18 |
Pharmaceutical patents: reconciling the human right to health with the incentive to invent
|
Khachigian, Levon M.
|
|
|
25 |
7 |
p. 1135-1141
|
artikel
|
| 19 |
Recombinant human H2 relaxin (serelaxin) as a cardiovascular drug: aiming at the right target
|
Bani, Daniele
|
|
|
25 |
7 |
p. 1239-1244
|
artikel
|
| 20 |
Role of oxidative stress in depression
|
Bhatt, Shvetank
|
|
|
25 |
7 |
p. 1270-1276
|
artikel
|
| 21 |
Shotgun drug repurposing biotechnology to tackle epidemics and pandemics
|
Mangione, William
|
|
|
25 |
7 |
p. 1126-1128
|
artikel
|
| 22 |
The prolyl hydroxylase inhibitor roxadustat: Paradigm in drug discovery and prospects for clinical application beyond anemia
|
Su, Kaijun
|
|
|
25 |
7 |
p. 1262-1269
|
artikel
|
| 23 |
Theranostic application of nanoemulsions in chemotherapy
|
Gorain, Bapi
|
|
|
25 |
7 |
p. 1174-1188
|
artikel
|
Tijdschrift beschrijving